Logo
    Search

    Burnbrae’s Mellon Says Shell and BP Are Good Long-Term Investments

    enJune 02, 2023

    Podcast Summary

    • High cost of US equities often overlookedRecognizing the high cost of US equities is crucial for investors, as overlooked expenses can impact returns. US stocks are expensive, but administrative hurdles and compliance requirements make it difficult for individuals to capitalize on cheap alternatives like UK equities.

      While US equities have been expensive for an extended period, and UK equities are considered cheap, the high cost of US equities is a significant issue that often goes unacknowledged. This discussion was inspired by the work of James Monti from asset manager GMO, who has previously warned about the high valuation of US stocks and the potential for mean reversion in corporate profit margins. The administrative hurdles and compliance requirements in investing can make it difficult for individuals to capitalize on such opportunities, as was the case before the 2008 financial crisis. The conversation also touched upon the challenges of adopting new technologies like cryptocurrency due to administrative complexities. Overall, the key takeaway is the importance of recognizing the high cost of US equities and the potential implications for investors.

    • US stocks are currently overvalued based on historical dataUS stocks' high valuations make them as expensive as during the tech bubble, potentially offering only a 3% real return for the next 10 years

      Despite the recent trends of growth outperforming value in the stock market, US stocks are currently overvalued based on historical data. James Montier, an economist, argues that even if corporate profit margins stay the same, US stocks' high valuations make them as expensive as they were during the tech bubble in 2000. If profit margins revert to their historical average, the CAPE ratio would be much higher than it is now, indicating a much lower expected real return for investors. Even if things go perfectly for the next 10 years, US stocks may only offer a 3% real return, which is not enough to justify the risk of buying equities. Montier suggests that the US running a permanent deficit is one reason for the high corporate profit margins. However, he does not address specific factors that could bring those margins down in this paper.

    • Brexit creating investment opportunity in UK equity marketDespite Brexit uncertainties, UK equity market is cheap and a good long-term investment opportunity due to discount caused by discouraging international investors

      Key takeaway from this conversation with Jim Mellon is that while the Brexit situation is not going as well as hoped by some, and not as badly as feared by others, it has created a significant opportunity for investors in the UK equity market due to the discount caused by discouraging international investors. Despite some concerns about the government's handling of the situation and the potential negative effects on the economy, Mellon believes that the UK equity market is phenomenally cheap and a good long-term investment opportunity. However, the British government's actions, such as increasing taxes and adding regulations, could negatively impact the economy and the equity market. Overall, the Brexit situation remains uncertain, but the potential investment opportunity is a positive aspect.

    • UK Equities: Attractive Investment Opportunities Despite ChallengesUK equities offer value due to discount compared to US companies and industries like fossil fuels, defense, financial services, insurance, investment trusts provide long-term confidence. UK's resilient economy, high services exports, and inward immigration contribute to future growth.

      Despite the concerns of excessive regulation and economic malaise in the UK, there are still valuable investment opportunities in the UK equity market. The UK economy, while facing challenges, remains resilient and is not unique in its struggles. The discount on UK equities compared to similar companies in the US makes them an attractive investment. Additionally, industries such as fossil fuels, defense, financial services, insurance, and investment trusts offer long-term confidence. London's position as a leading financial capital in the world is not in jeopardy, and the economy's strength lies in its high services exports. Despite government efforts to restrain the economy, the UK's resilience and inward immigration are expected to contribute positively to its growth in the coming years.

    • Managing Demographic Changes for Economic SustainabilityAs the world's population ages rapidly, managing demographic changes is crucial for economic sustainability. Efforts should focus on preventing people from becoming frail and encouraging longer working lives, rather than solely importing labor.

      The current trend of immigration may not necessarily lead to an improvement in individuals' living standards in the short term, potentially even diluting GDP per capita. However, as developed countries face a demographic crisis with population collapse in many places, there will be a need for migrant labor in the future. Instead of focusing solely on importing people, efforts should be made to manage economies and societies to cope with aging populations. This includes preventing people from becoming frail and encouraging longer working lives. The world's population is aging rapidly, with more than half of the G7 population expected to be over 65 years old by 2070. It's crucial to address this issue proactively to prevent social unrest and ensure economic sustainability. While Japan is an example of a society that has begun to adapt, its approach may not be suitable for all countries. The key is to find a balance between managing demographic changes and ensuring the well-being of the population.

    • Investing in Japan: Optimism Amidst Economic InstabilityWarren Buffett's continued investment in Japanese conglomerates and trading companies signals long-term growth potential, but junior analysts' entitlement may hinder success. Stay informed and committed to investments during uncertain economic times.

      Despite concerns of economic instability and a potential recession, some investors, including Warren Buffett, remain optimistic about the long-term prospects of investing in Japan. The country's large conglomerates and trading companies have seen significant growth, and Buffett's continued investment in them serves as a strong endorsement. However, there's a growing sense of entitlement among junior analysts that they don't need to put in the same level of effort and research that was once required. Despite the challenges, it's important for investors to stay informed and committed to their investments, especially in uncertain economic times. For more insights on money, markets, and politics, tune in to The Big Take DC every Thursday on the Iheartradio app, Apple Podcasts, or wherever you get your podcasts.

    • Monetarists propose relationship between money supply and stock marketsMonetarists suggest a link between money supply and stock markets, but market performance isn't guaranteed. Overpriced markets may deter investment, while underpriced ones attract it. The value of currencies and specific stocks require individual analysis.

      The relationship between the money supply and stock markets, as proposed by monetarists like John Greenwood, can be effective but is not a guaranteed indicator of market performance. Markets, such as Japan in the late 1980s, can become overpriced and unattractive for investment. Conversely, underpriced markets, like the UK, may attract mergers and acquisitions from private equity firms. The value of the yen, despite its undervaluation, remains a mystery, and the Japanese economy and stock market are not favored by many investors. The Japanese trusts, which have underperformed, have missed out on the value end of the market, and individual stocks, such as Sony and Toyota, offer potential value. However, the rise of electric vehicles in China and the challenges they present, such as limited export capabilities and fire hazards, should be carefully considered.

    • Challenges in the Rollout of Electric Vehicles and Industry ChangesDespite the push towards electric vehicles, challenges like battery fires, industry adjustments, and financial struggles persist. Productivity declines and healthcare costs rise in Western countries.

      The rollout of electric vehicles (EVs) faces challenges such as fires caused by batteries and their heavier weight. Additionally, the UK government's plan to stop producing conventional cars by 2030 might not be feasible and could harm the industry. Productivity in the car sector has declined due to environmental regulations. Tesla, a major player in the EV market, is facing financial struggles and its market cap is much higher than that of its competitors, some of which have more experience in producing cars. Life expectancy has stalled or even decreased in some Western countries due to the pandemic, and the US is expected to spend a large portion of its GDP on healthcare. The promise of extending human life through biological interventions is still a work in progress.

    • Investment and Research in Biotech and Agtech: Extending Human Life and Producing Alternative Food SourcesJeff Bezos, Google, and other investors are funding research in biotech and agritech for healthier aging populations, reducing healthcare costs, and addressing food security. Companies like Juvenescence and Altos Labs are making progress in human longevity, while the UAE leads in agritech with factories for novel protein production.

      There is growing investment and research in the fields of biotechnology and agritech, specifically in areas related to extending human life and producing alternative sources of food, such as cultivated meat. These areas hold promise for improving the health and productivity of the aging population, reducing healthcare costs, and addressing food security issues. Notable investors include Jeff Bezos and Google, and companies like Juvenescence and Altos Labs are making strides in developing interventions to improve the robustness of older people. In the agritech sector, the UAE is leading the way in building factories for producing novel proteins through cellular agriculture and precision fermentation. While there are currently no clear investment opportunities for the average investor in these areas, it's recommended to keep a close eye on developments and potential public offerings from companies like Juvenescence.

    • Investing in agronomics and alternative proteins can lead to significant returnsInvesting in agronomics and alternative proteins, like cell-based meat, can yield substantial returns. Starting your own company provides a larger share and greater potential upside.

      Investing in agronomics and backing scientists and entrepreneurs to develop their own companies in the biotech industry can lead to significant returns, as seen with Agronomics' nearly 4x increase in NAV. Starting your own company, like Liberation Labs, provides a larger share of the company and greater upside potential. The market for alternative proteins, such as cell-based meat, is growing rapidly and presents an exciting industry opportunity. Despite economic uncertainties, it's essential to differentiate between lab-grown, bioidentical meats and plant-based meat substitutes. In the political sphere, the Big Take DC podcast covers how money, politics, and power shape government and its impact on voters. While there may be concerns about economic instability, the distinction between real and fake market indicators is crucial to understanding the current economic landscape.

    • A sustainable alternative to conventional farmingClean meat, grown in labs, offers a more sustainable solution to traditional farming by reducing water usage, antibiotic and hormone use, and animal suffering, while addressing concerns related to mercury and microplastics in fish and the environmental impact of animal agriculture.

      Clean meat, which is grown in a lab, offers a more sustainable alternative to conventionally farmed meat, fish, and other animal products. This includes lab-grown meat for humans, as well as alternatives for pet food. Clean meat production does not contribute to the displacement of water resources, antibiotic and hormone use, or animal suffering on the scale of conventional farming. While plant-based food companies may face competition, clean meat companies are making strides in gaining acceptance and endorsements from industry leaders. Additionally, clean meat production addresses concerns related to mercury and microplastics in fish and the environmental impact of animal agriculture in countries like India and China. Although it may take many years to significantly impact the food market, clean meat production offers a promising solution to the environmental and ethical challenges associated with traditional animal agriculture.

    • Jim Mellon's Preference for Gold Over BitcoinBusinessman Jim Mellon advocates for gold investment due to its stability and lower volatility compared to Bitcoin, and donates book proceeds to charity

      Jim Mellon, a well-known businessman and co-host of the Longevity Forum, strongly prefers gold over Bitcoin due to its stability and lower volatility. He believes that gold has retained value throughout the years and is a safer investment compared to Bitcoin's extreme price fluctuations. Additionally, Mellon is passionate about charitable work and recently wrote a children's book called "Juno's Ark" to raise funds for Compassion, World Farming, and a dog shelter in Ibiza. The book, aimed at 8 to 12-year-olds, follows the adventure of a dog named Juno as she rescues cruelly farmed animals and discovers cell agriculture. All proceeds from the book go directly to these charities.

    Recent Episodes from Merryn Talks Money

    Why UK Bosses Need More Skin in The Game

    Why UK Bosses Need More Skin in The Game

    Activist investors are on a mission to persuade large British businesses to move from London’s stock market to those of New York. Liad Meidar, founder and managing partner of Gatemore Capital Management, joins this week’s episode of Merryn Talks Money to discuss what’s driving this westward push and the steps London can take to head it off. 

    The main incentive for companies to drop London for the Big Apple is the valuation gap. FTSE 100 companies trade at little more than half of the valuation of those on the S&P 500 on a forward price-to-earnings basis. The reason? Meidar says it’s the cost of capital, the UK takeover code and how board members are incentivized. Address those issues, and you’re on your way to solving the problem. 

    See omnystudio.com/listener for privacy information.

    Merryn Talks Money
    enJune 28, 2024

    Why Now Is the Moment for Bitcoin and Gold

    Why Now Is the Moment for Bitcoin and Gold

    Regular listeners of the Merryn Talks Money podcast know that Merryn Somerset Webb usually ends her interviews with one question. If you had to invest all of your money into one of these assets, and hold it for the next 10 years, which would it be: Bitcoin or gold? In this week’s episode, she makes that question the foundation for a conversation with Charlie Morris, chief investment officer and founder of ByteTree, and Alexander Chartres, a fund manager at Ruffer. 

    The episode was taped in front of audience at the Bloomberg offices in London. 

    Want to see Merryn live? Check out her shows in Edinburgh at Fringe Festival this August! 

    See omnystudio.com/listener for privacy information.

    Merryn Talks Money
    enJune 14, 2024

    Reasons to Put Your Money in a ‘Fragile’ Europe

    Reasons to Put Your Money in a ‘Fragile’ Europe

    On this week’s Merryn Talks Money, host Merryn Somerset Webb speaks with Daniel Avigad, partner and fund manager at Lansdowne Partners, a global investment management boutique entirely focused on active equities investing. He explains why Europe, though debt heavy and over-regulated, may actually be a place to put your money.

    See omnystudio.com/listener for privacy information.

    Merryn Talks Money
    enJune 07, 2024

    Living Longer Means Rethinking How You Work Right Now

    Living Longer Means Rethinking How You Work Right Now

    If aging doesn’t happen all at once, why should retirement? That’s the question Merryn Somerset Webb explores with economist and author Andrew J Scott in this week’s episode of Merryn Talks Money. They discuss the opportunities and challenges of living longer in the 21st century, and the complications it may inflict on your financial planning. 

    Plus, senior reporter John Stepek joins to talk the quadruple lock and the pensions bidding war. 

    See omnystudio.com/listener for privacy information.

    Merryn Talks Money
    enMay 31, 2024

    How To Protect Your Pension From a New Government

    How To Protect Your Pension From a New Government

    A general election in the UK has been called for July 4. What does that mean for your money—and is there anything you can (or should) do in advance of a possible tide of new policy?

    Those are the questions host Merryn Somerset Webb and senior reporter John Stepek explore with guests Helen Thomas, chief executive of macroeconomic consultancy BlondeMoney, and Tom McPhail, director of public affairs at The Lang Cat. 

    See omnystudio.com/listener for privacy information.

    Merryn Talks Money
    enMay 24, 2024

    The Argument Against Relative Performance

    The Argument Against Relative Performance

    Tellworth’s John Warren tells Merryn Talks Money investors aren’t interested in a manager’s record versus an index—they just want to make money.

    And it has happened again. Another new high for the FTSE 100. Merryn would love to talk about something else, but John Stepek can't. 

    See omnystudio.com/listener for privacy information.

    Merryn Talks Money
    enMay 17, 2024

    Why Everyone Believes What They Want to Believe with Alex Edmans

    Why Everyone Believes What They Want to Believe with Alex Edmans

    On this week’s episode of Merryn Talks Money, London Business School professor and author Alex Edmans joins to discuss his new book, May Contain Lies. Edmans explains why he believes that stories, statistics and studies exploit pre-existing biases.

    Plus, John Stepek joins to discuss yet another boring Bank of England rate decision. 

    Emails to merrynmoney@bloomberg.net

    See omnystudio.com/listener for privacy information.

    Making the Case for Active Investing

    Making the Case for Active Investing

    Downing Fund Managers’ Simon Evan-Cook joins this week to talk about the case for active versus passive investing.

    Cook says Jack Bogle, founder of The Vanguard Group and arguably the father of passive investing, did “more for individual wealth than anyone in history.” He deserved a knighthood for creating a low risk, reliable and comprehensive way of investing, Cook says. Nevertheless, the fund manager explains why he’s an investor in active funds, and discusses how to find the rare manager who might make you real money over the long term. 

    See omnystudio.com/listener for privacy information.

    Why Sunak May Quit Ahead of a July 4th Election

    Why Sunak May Quit Ahead of a July 4th Election

    Get ready for a UK election this summer, says Helen Thomas, an ex-adviser to former Conservative finance minister George Osborne and CEO of BlondeMoney. On this week’s Merryn Talks Money, she joins Merryn Somerset Webb to explain her core scenario for the British government: Rishi Sunak will resign and hand over to Penny Mordaunt, the House of Commons leader. She will call a July 4th election — and Labour leader Keir Starmer will be prime minister by the middle of July.

    Plus, John Stepek joins to discuss a new high in the FTSE 100 and Opinion Columnist Adrian Wooldridge joins the post-interview discussion to share his views on Helen's predictions. 

    Love/Hate mail to the usual address: merrynmoney@bloomberg.net

    See omnystudio.com/listener for privacy information.

    Related Episodes

    Biotech Boom ETFs

    Biotech Boom ETFs

    Learn which biotech and health care ETFs are performing the best.

    I also discuss the unemployment report that came out today and why we are not in a depression.

    The link to the chart is here.

    Are you investing well for financial freedom...or not?

    As we live our lives, we have seen enormous money be made in real estate, technology stocks, etc. and have seen wild swings in markets before. They can feel scary at the time, but in hindsight are often tremendous opportunities for future financial success.

    If you only knew where to invest for the long-term, what a difference it would make, because the difference between investing $100k and earning 2% or 10% on your money over 30 years, is the difference between it growing to $181,136 or $1,744,940, an increase of over $1.5 million dollars.

    Your compounding rate, and how well you invest, matters! 

    INTERESTED IN THE BE WEALTHY & SMART VIP EXPERIENCE?

    -Asset allocation model with ticker symbols and % to invest

    -Monthly investing webinars with Linda

    -Private Facebook group with daily insights

    -Weekly stock market commentary email

    -Lifetime access

    -US and foreign investors, no minimum $ amount required

    For a limited time, enjoy a 50% savings. More information is here or have complimentary consultation with Linda to answer your questions, here.

    PLEASE REVIEW THE SHOW ON ITUNES

    If you enjoyed this episode, please subscribe and leave a review. I love hearing from you! I so appreciate it!

    SUBSCRIBE TO BE WEALTHY & SMART

    Click Here to Subscribe Via iTunes

    Click Here to Subscribe Via Stitcher on an Android Device

    Click Here to Subscribe Via RSS Feed

    WEALTH HEIRESS TV

    Please subscribe to Wealth Heiress TV YouTube channel (it’s not just for women, it’s for men too!), here.

    PLEASE LEAVE A BOOK REVIEW

    Leave a book review on Amazon here.

    Get my book, “You’re Already a Wealth Heiress, Now Think and Act Like One: 6 Practical Steps to Make It a Reality Now!”

    Men love it too! After all, you are Wealth Heirs. :)

    Available for purchase on Amazon.

    International buyers (if you live outside of the US) get my book here.

    WANT MORE FROM LINDA?

    Check out her programs.

    Join her on Instagram.

    WEALTH LIBRARY OF PODCASTS

    Listen to the full wealth library of podcasts from the beginning. Use the search bar in the upper right corner of the page to search topics.

    TODAY'S SPONSOR

    I want to take a few seconds to tell you about how I “read” more books and stay ahead of the curve. It’s by not reading books, but instead listening to them – like you are right now! With Audible, there are over 150,000 titles to choose from for your iPhone, Android, Kindle or mp3 player and…your first audiobook is FREE!

    I suggest you get the audio book of Think and Grow Rich, or you can check out my website Resources page where I list all of my favorite financial books and you see exactly what books I have read and recommend you read. Then get started with Audible by visiting https://lindapjones.com/FreeBook and order your first audio book free! Get Think and Grow Rich or another book from my recommend list, and be sure to get started checking off the books you want to read with your free book from Audible!

    Be Wealthy & Smart,™ is a personal finance show with self-made millionaire Linda P. Jones, America’s Wealth Mentor.™ Learn simple steps that make a big difference to your financial freedom. 

    (Some links are affiliate links. There is no additional cost to you.)

    E1022: One Drop CEO & Founder Jeff Dachis helps people with diabetes manage & improve their blood-sugar levels, shares insights on making data actionable, recent strategic partnership with Bayer, issues with US healthcare & potential life-expansion

    E1022: One Drop CEO & Founder Jeff Dachis helps people with diabetes manage & improve their blood-sugar levels, shares insights on making data actionable, recent strategic partnership with Bayer, issues with US healthcare & potential life-expansion
    0:47 Jason intros One Drop CEO Jeff Dachis
    2:37 What was Jeff's original vision with One Drop? How has it evolved over time?
    5:39 How did One Drop go from collecting data to making it actionable?
    8:09 How important was getting the One Drop retail products into Apple stores?
    9:46 Raising money as a hardware healthcare product
    15:23 How did the Bayer partnership come about?
    17:57 Have any major drug companies built software to manage what happens after taking medication?
    21:19 What is the One Drop business today? How does coaching play into their product?
    30:27 Who are One Drop's enterprise sales targets? Why don't more companies have health practitioners in-house?
    36:37 Should employers be tied to healthcare?
    40:04 What contributes most to the diabetes epidemic?
    44:46 What are continuous glucose monitors? How do they help?
    48:34 Why is insulin so expensive in the US compared to other countries?
    51:47 Will we ever be able to know our blood sugar levels without intrusive hardware?
    57:47 Will humans see average life-expansion into the 100's over the next few decades?
    1:02:12 How gene-therapy becomes dangerous

    Fred Bamber “The Perfect Startup Portfolio” Ep. 5 Experienced Venture Capitalist and Wise Angel Investor

    Fred Bamber “The Perfect Startup Portfolio” Ep. 5 Experienced Venture Capitalist and Wise Angel Investor

    As a venture capitalist Fred Bamber helped build such successful companies as Interleaf, Q1 Labs and Volt Server. Now working as an angel investor Fred is invested in such exciting companies as SQZ Biotech, Pixability, Streamroot and ViralGains. In his self-effacing and modest way, Fred reveals deep wisdom gained from 75 investments in his venture capital career. Here are some of the topics covered:

    • Fred Bamber Finds His Career Path
    • Avoiding the Military Draft Led Him to Work for His First Startup
    • Fred Bamber & Friend Found a Venture Fund – Consulting vs. Venture Capital
    • IPOs Then & Now
    • Investment in Interleaf Makes His First Fund a Success!
    • Two Ways of Connecting in the World of Venture Capital – Via Success & Via Failure
    • Several Losing Investments in Companies Seeking to Exploit the Piezoelectric Effect
    • Themes In Angel Investing – Investing in Brand New Fields i.e. White Spaces
    • ‘…Oracle has a huge go-to-market cost, and engineering is a tiny bit of it.’
    • Technology Causing Convergence of Consumer & Enterprise Businesses
    • Startups with Jeff Weiss - The Perils of Being Early – Early Augmented Reality (AR)
    • Rich Lane & Reflection Technology – Augmented Reality-like – Projecting Text into the Eye
    • Progress of Technology Is Painful – “Thread Across The Ocean” by John Steele Gordon
    • Michael Lewis & Drama in Business – Paul English & “A Truck Full of Money”
    • Paul English Finds His Inner Entrepreneur after Interleaf
    • Robert P. Smith & “Riches Among the Ruins” – Not Made for Working In Large Companies
    • VCs Should Be Humble
    • Fred Talks About His Investment in Volt Server
    • Uber & Washington, D.C. Cabs
    • Peter Thiel’s Critique of Entrepreneurship – “We Were Promised Flying Cars and We Got 140 Characters”
    • SQZ Biotech & Massachusetts Materials Technology
    • What Fred Looks For In a Startup – Technology, Coachability, Tenacity, Openess – VC vs Angel
    • Startups Should Report Frequently – Reports Should Tie In to Previous Reports i.e. Close the Loop
    • Angel Investor Should Be Father Confessor without the Ave Marias
    • Bettina Hein & Pixability – Example of Determination Combined with Openess
    • Beth Marcus’ Test For Listening
    • Fred Bamber’s Suggestion of the Perfect Number of Angel Investments in a Portfolio
    • Why Sal Daher Is Invested In About 42 Companies
    • The Role of a Board of Directors – Father Confessor
    • Fred’s Favorite Pivot – Q1 Labs (IBM)
    • Fred Also Likes Streamroot’s Pivots
    • Q1 Labs Pivot Runs Counter the Received Wisdom of Startups Needing a Narrow Focus to Succeed
    • “Crossing the Chasm” by Geoffrey A. Moore
    • “Why Knowledge Matters” by E.D. Hirsch, Jr.

    Acorn Biolabs with CEO Dr. Drew Taylor

    Acorn Biolabs with CEO Dr. Drew Taylor

    Acorn is a Canadian healthcare startup that is seeing impressive growth and now expansion into the U.S. market.

    The first non-invasive solution to preserving your younger follicle cells for use in future cell treatments. · Harvest your best cells · Confirm their viability.

    Acorn is a healthcare technology company focused on helping people prepare for future cell treatments with autologous live cell cryopreservation.